Financial News Feed

Previous Hold Today ADMP ranks #3407 as HOLD CANDIDATE. Next Hold
Today ADMP ranks #3407 as HOLD CANDIDATE.

ADMP stock Adamis Pharmaceuticals Corporation

ADMP stock
Adamis Pharmaceuticals Corporation

Ichimoku traders are closely watching shares of Adamis Pharmaceuticl (ADMP) as the equity’s price has tipped below the Tenkan moving average line, creating an environment ripe for a potential near-t...

Read more

ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ:ADMP) Files An 8-K Other EventsItem 8.01 On January 16, 2019, Adamis Pharmaceuticals Corporation (the Company) issued a press release announcing that its mar...

Read more

ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ:ADMP) Files An 8-K Financial Statements and ExhibitsItem 9.01 Financial Statements and Exhibits (d) Exhibits. 99.1 Press release dated January 16, 2019. Adam...

Read more

Adamis Pharmaceuticals Corp (NASDAQ:ADMP) shares rose 0.3% during mid-day trading on Friday . The stock traded as high as $2.95 and last traded at $2.89. Approximately 354,147 shares were traded durin...

Read more

Adamis Pharmaceuticals (NASDAQ:ADMP) today announced that its marketing and commercial partner, Sandoz, a Novartis division, has launched SYMJEPI (epinephrine) 0.3 mg Injection in the US market for th...

Read more

Shares of Adamis Pharmaceuticals Corp (NASDAQ:ADMP) saw an uptick in trading volume on Thursday . 2,014,049 shares traded hands during mid-day trading, an increase of 364% from the previous session’...

Read more

Shares of Precision Therapeutics Inc (NASDAQ:AIPT) soared Thursday after it announced that its Skyline Medical division significantly expanded its footprint in New England with the sale of six STREAMW...

Read more

B.Riley FBR analyst Andrew D’silva maintained a Hold rating on Adamis Pharma (ADMP) today and set a price target of $2. The post Adamis Pharma (ADMP) Receives a Hold from B.Riley FBR appeared first ...

Read more

Shares in Adamis Pharmaceuticals Corp (NASDAQ:ADMP) soared Thursday after the biotech said its partner Sandoz Inc launched a SYMJEPI (epinephrine) 0.3 mg injection in the United States for the emergen...

Read more

Shares in Adamis Pharmaceuticals Corp (NASDAQ:ADMP) soared Thursday after the biotech said its partner Sandoz Inc launched a SYMJEPI (epinephrine) 0.3 mg injection in the United States for the emergen...

Read more

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Adamis Pharma (ADMP), with a price target of ... The post Adamis Pharma (ADMP) Gets a Buy Rating from Maxim Group...

Read more

Adamis Pharmaceuticals Corp. shares surged in the extended session Wednesday after the biotech company said its partner Sandoz Inc. launched an alternative to epinephrine auto-injectors like Mylan NV'...

Read more

Adamis Pharmaceuticals Corp. shares surged in the extended session Wednesday after the biotech company said its partner Sandoz Inc. launched an alternative to epinephrine auto-injectors like Mylan NV'...

Read more

SAN DIEGO, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) today announced that its marketing and commercial partner, Sandoz Inc. (Sandoz), a Novartis division, ha...

Read more

(MENAFN - GlobeNewsWire - Nasdaq) itemprop="articleBody">SAN DIEGO, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that its mar......

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank